Delaware Biotech Company Considers Sale After Drug Trial Setback

Theravance Biopharma announced Tuesday it will explore strategic options, potentially including selling the company, following disappointing results from a clinical trial. The company's experimental medication for a rare blood pressure condition failed to show significant benefits over a placebo in late-stage testing.

A Delaware-area biotechnology company announced Tuesday it will explore selling itself or other strategic alternatives following disappointing results from a major drug trial.

Theravance Biopharma revealed that its experimental medication ampreloxetine did not achieve its primary objectives in advanced clinical testing. The treatment was designed to help patients with multiple system atrophy, an uncommon condition that causes potentially dangerous blood pressure drops when patients stand up.

According to the company’s announcement, participants who received the experimental treatment showed no significant symptom improvements when compared to those who received inactive placebo treatments.

The biopharmaceutical firm has enlisted investment banking firm Lazard to assist with evaluating its options, though company officials cautioned that no transaction is guaranteed to occur.

Trading of Theravance shares was suspended during pre-market hours following the announcement.

More from TV Delmarva Channel 33 News

  • NY Fed Chief Hints at Future Rate Cuts Despite Middle East Tensions

    New York Federal Reserve President John Williams indicated Tuesday that additional interest rate reductions could be coming if inflation continues to cool as anticipated. However, Williams avoided discussing how the ongoing Iran conflict might affect the U.S. economy, even as global markets show concern about rising energy costs.

  • State Department Evacuates Staff, Tells Americans to Leave Middle East

    The U.S. State Department has withdrawn non-essential personnel from multiple embassies across the Middle East and is urging all American citizens to immediately exit the region. However, with major airports closed due to ongoing U.S.-Israeli military operations against Iran, thousands of Americans remain stranded with limited evacuation options.

  • Maryland Offers Financial Help for Farmers’ Spring Manure Management

    The Maryland Department of Agriculture is reminding farmers they can receive financial assistance for transporting manure and liquid injection costs this spring. The cost-share program helps cover expenses for moving manure to fields with appropriate soil phosphorus levels.

  • Nations Rush to Evacuate Citizens as Middle East Flights Halted After Strikes

    Countries worldwide are scrambling to bring home hundreds of thousands of their citizens stranded across the Middle East after airspace closures following U.S. and Israeli military actions against Iran. Multiple nations have launched charter flights and evacuation efforts, though closed airspace is complicating rescue operations.